Because of Symbicort's immunosuppressive effect, its use may need to be delayed until the infection is fully treated. Animal studies suggest a potential risk of fetal harm when using Symbicort but ...

A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper competition for the ageing blockbuster. The US District Court for the Northern District of West ...

Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...